Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I agree!
Market Potential - There are 1,200 dermatologists the company is targeting. These 1200 do a great majority of dermatology business in the United States. In the target market, there were 4.5 million procedures last year and it amounted to $11 billion.
The company is excited about the laVív platform after approval for the first indication. Fibrocell thinks it will be easy to extend the laVív platform into other indications as the way to produce the sales is exactly the same. The CEO noted that laVív can be easily developed for other indications such as small lines and wrinkles around lips and eyes, acne scars, and burn scars. The CEO added that there is a very "substantial" opportunity in these markets as there is no competition in these areas. The company already has some promising data on burn scars and is in the process of setting up a meeting with the FDA on its trials of laVív for acne scars.
According to a study done by the company, 95% of the people felt the same or better at 12 months versus at six months after injection. Fibrocell is happy with the labeling and it will be available to view on their website shortly.
Okay juslookn stay on the sidelines!
I like this part in ron's shareholder notes:
- Company is pursuing the Chinese market which is enormous. They have a JV with a company in China. If they receive FDA approval, the believe strongly China will approve LaViv. They have a manufacturing facility in Shang Du which is a highly populated area. Apple computer has an office there.
also equal to Botox in price in the long term!
And maybe even cheaper in price in longer term.
Time to retrace back up!
that fat lady needs some Fibrocell!
Sellers every other minute!
who is shorting?
i agree!
Nice and I think you get a free t-shirt!
So Diluted..... this started off well.
Hope for the best!
GLTA!
must be nice to be you!
must be nice to be you!
Not IHUB money here!
I hope everyone made money on FCS$ Now it's time to put your smart money here!
112 k buy
very nice!
250k buy
250k buy
The technology is there and RISK is gone!
remember JV in China.
once we have a US partner..... gonna get crazy!
undervalued at 2-3 shouldn't sell here!
The technology is there and RISK is gone!
remember JV in China.
once we have a US partner..... gonna get crazy!
undervalued at 2-3 shouldn't sell here!
we won't see a big pop or gap unless we have news of partnership right?
or is the JV in china worth holding today and tomorrow?
just your thoughts?
whatisthecolorofmone same plan here!
here too on Scotts
Nice PIC!
nice!!!!!
40k nice!
I think the are finishing up the website!
CURRENTLY UPDATING. Text and placements may be changing during this final process
I think the are finishing up the website!
CURRENTLY UPDATING. Text and placements may be changing during this final process
I think because of the Vogue article if FCSC get approval I might hold some long. Everyone is thinking $3 if approved. I think over $5 just because of the Vogue article.
don't like it because of that reason!
El Jefe always keepin it real!
I agree!
is the article on line?
can someone post the link or scan it?